XML 45 R34.htm IDEA: XBRL DOCUMENT
v3.26.1

COLLABORATION AND LICENSE AGREEMENTS (Details) - USD ($) |  |  |  | 3 Months Ended |  |
--- | --- | --- | --- | --- | --- | ---
Mar. 12, 2026 | Jan. 06, 2025 | Feb. 05, 2024 | Mar. 31, 2026 | Mar. 31, 2025 | Dec. 31, 2025 | Jan. 07, 2024
Collaboration and License Agreements [Line items] |  |  |  |  |  |  |
Decrease in fair value of equity |  |  |  | $ 2,951,000 | $ (49,000) |  |
TG License | License |  |  |  |  |  |  |
Collaboration and License Agreements [Line items] |  |  |  |  |  |  |
Collaborative arrangement, upfront payments and liabilities |  | $ 2,500,000 |  |  |  |  | $ 10,000,000.0
Sale of stock, number of shares issued in transaction (in shares) |  | 220,712 | 97,360 |  |  |  |
Percentage of premium over the volume-weighted-average-price of the company’s common stock (as a percent) |  | 100.00% | 100.00% |  |  |  |
Number of trading days prior to agreement to determine price per share |  | 30 days | 30 days |  |  |  |
Sale of stock, price per share (in USD per shares) | $ 11.1660 | $ 11.33 |  |  |  |  |
Revenue recognized | $ 7,500,000 |  |  | 6,800,000 | 0 |  |
Additional milestone |  |  |  |  |  |  | $ 288,600,000
Contract with customer, liability, revenue recognized upon issuance of shares |  |  |  | 700,000 |  |  |
Contract with customer, liability, revenue recognized as transaction price |  |  |  | 6,800,000 |  |  |
TG License | License | Payment Tranche One |  |  |  |  |  |  |
Collaboration and License Agreements [Line items] |  |  |  |  |  |  |
Collaborative arrangement, upfront payments and liabilities |  |  | $ 5,250,000 |  |  |  |
Revenue recognized | 5,250,000 |  |  |  |  |  |
TG License | License | Payment Tranche Two |  |  |  |  |  |  |
Collaboration and License Agreements [Line items] |  |  |  |  |  |  |
Collaborative arrangement, upfront payments and liabilities |  |  | $ 2,250,000 |  |  |  |
Revenue recognized | $ 2,250,000 |  |  |  |  |  |
Shares available for exchange (in shares) | 201,504 |  |  |  |  |  |
Novartis Pharma AG | Discovery and Development |  |  |  |  |  |  |
Collaboration and License Agreements [Line items] |  |  |  |  |  |  |
Collaborative arrangement, upfront payments and liabilities |  |  |  | 0 |  | $ 0 |
Revenue recognized |  |  |  | 0 | 100,000 |  |
iECURE | Development and License |  |  |  |  |  |  |
Collaboration and License Agreements [Line items] |  |  |  |  |  |  |
Decrease in fair value of equity |  |  |  | 0 | $ 0 |  |
Agriculture Industry Collaboration Partner | Research and License |  |  |  |  |  |  |
Collaboration and License Agreements [Line items] |  |  |  |  |  |  |
Revenue recognized |  |  |  | $ 4,000,000.0 |  |  |

X
- Definition Collaborative Arrangement, Shares Available For Exchange + References No definition available. + Details
Name: | dtil_CollaborativeArrangementSharesAvailableForExchange
Namespace Prefix: | dtil_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Contract With Customer, Liability, Revenue Recognized As Transaction Price + References No definition available. + Details
Name: | dtil_ContractWithCustomerLiabilityRevenueRecognizedAsTransactionPrice
Namespace Prefix: | dtil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Contract with Customer, Liability, Revenue Recognized Upon Issuance of Shares + References No definition available. + Details
Name: | dtil_ContractWithCustomerLiabilityRevenueRecognizedUponIssuanceOfShares
Namespace Prefix: | dtil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage of premium over the volume-weighted-average-price of the company’s common stock. + References No definition available. + Details
Name: | dtil_PercentageOfPremiumOverVolumeWeightedAveragePriceOfCompanysCommonStock
Namespace Prefix: | dtil_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Revenue, Remaining Performance Obligation, Variable Consideration, Additional Milestone, Amount + References No definition available. + Details
Name: | dtil_RevenueRemainingPerformanceObligationVariableConsiderationAdditionalMilestoneAmount
Namespace Prefix: | dtil_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Stock Issued, Price Per Share, Number Of Trading Days Prior To Agreement + References No definition available. + Details
Name: | dtil_StockIssuedPricePerShareNumberOfTradingDaysPriorToAgreement
Namespace Prefix: | dtil_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 808 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1 + Details
Name: | us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-11 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2 + Details
Name: | us-gaap_ContractWithCustomerLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 8 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8 + Details
Name: | us-gaap_ContractWithCustomerLiabilityRevenueRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(3)(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479536/321-10-50-4 + Details
Name: | us-gaap_EquitySecuritiesFvNiGainLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | srt_CounterpartyNameAxis=dtil_TGLicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_LicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dtil_PaymentTrancheAxis=dtil_PaymentTrancheOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dtil_PaymentTrancheAxis=dtil_PaymentTrancheTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=dtil_NovartisPharmaAGMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=dtil_DiscoveryAndDevelopmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=dtil_IECUREMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=dtil_DevelopmentAndLicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=dtil_AgricultureIndustryCollaborationPartnerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=dtil_ResearchAndLicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |